Bifunctional drugs for the treatment of asthma and chronic obstructive pulmonary disease

Page Clive, Cazzola Mario

Source: Eur Respir J 2014; 44: 475-482
Journal Issue: August
Disease area: Airway diseases

Congress or journal article abstractFull text journal articlePDF journal article, handout or slides

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
Page Clive, Cazzola Mario. Bifunctional drugs for the treatment of asthma and chronic obstructive pulmonary disease. Eur Respir J 2014; 44: 475-482

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Therapeutic responses in asthma and chronic obstructive pulmonary disease
Source: Annual Congress 2008 - PG17 - An expert view of the differences between asthma and COPD
Year: 2008


Bronchodilators in chronic obstructive pulmonary disease
Source: ISSN=ISSN 1025-448x, ISBN=ISBN 1-904097-48-0, page=266
Year: 2006

Emerging drugs in chronic obstructive pulmonary disease
Source: Annual Congress 2010 - Emerging drugs in COPD
Year: 2010

Are severe asthma and chronic obstructive pulmonary disease the same disease?
Source: Annual Congress 2006 - Smoking asthmatics – a neglected population?
Year: 2006


Inferon efficacy in the treatment of chronic obstructive pulmonary disease
Source: Annual Congress 2008 - Inflammatory trigger mechanisms in asthma and COPD
Year: 2008

Influence of bronchodilators on pulmonary hypertension in patients with chronic obstructive pulmonary disease (COPD)
Source: Eur Respir J 2003; 22: Suppl. 45, 427s
Year: 2003

The impact of using different symptom-based exacerbation algorithms in patients with COPD
Source: Eur Respir J 2011; 37: 1260-1268
Year: 2011



Effect of systemic corticosteroids for acute exacerbations of chronic obstructive pulmonary disease
Source: Eur Respir J 2006; 28: Suppl. 50, 624s
Year: 2006

Antibiotics in acute exacerbations of chronic obstructive pulmonary disease
Source: Annual Congress 2009 - Exacerbations of COPD and bronchiectasis: aetiology and treatment
Year: 2009

Influence of bronchodilators on pulmonary hypertension in patients with chronic obstructive pulmonary disease (COPD) and COPD concomitant with bronchial asthma
Source: Eur Respir J 2004; 24: Suppl. 48, 521s
Year: 2004

Therapeutic approaches in the chronic obstructive (COPD) pulmonary disease
Source: Eur Respir J 2002; 20: Suppl. 38, 472s
Year: 2002

Doxycycline for exacerbations of chronic obstructive pulmonary disease in outpatients: who benefits?
Source: ERJ Open Res, 6 (2) 00099-2020; 10.1183/23120541.00099-2020
Year: 2020



Systemic effects of chronic obstructive pulmonary disease
Source: Eur Respir J 2003; 21: 347-360
Year: 2003



Emerging anti-inflammatory strategies for COPD},
Source: Eur Respir J 2012; 40: 724-741
Year: 2012



Role of inhaled antioxidants in chronic obstructive pulmonary disease
Source: Eur Respir J 2005; 26: Suppl. 49, 717s
Year: 2005

Mechanisms in chronic obstructive pulmonary disease: comparisons with asthma
Source: Annual Congress 2008 - PG17 - An expert view of the differences between asthma and COPD
Year: 2008

Evaluation of bronchodilator responses in chronic obstructive pulmonary disease patients
Source: Eur Respir J 2002; 20: Suppl. 38, 247s
Year: 2002

Home hospitalisation of exacerbated chronic obstructive pulmonary disease patients
Source: Eur Respir J 2003; 21: 58-67
Year: 2003



Efficacy of lasolvan in the treatment of patients with chronic obstructive pulmonary disease
Source: Annual Congress 2009 - Drug effects in COPD
Year: 2009


Cilomilast is efficacious in chronic obstructive pulmonary disease (COPD)
Source: Eur Respir J 2003; 22: Suppl. 45, 68s
Year: 2003